SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-009996
Filing Date
2020-11-30
Accepted
2020-11-30 15:58:18
Documents
1
Period of Report
2020-11-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-50344.html 4  
1 PRIMARY DOCUMENT marketforms-50344.xml 4 14594
  Complete submission text file 0001214659-20-009996.txt   16172
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Issuer) CIK: 0001625288 (see all company filings)

IRS No.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address
Greenberg Richard S (Reporting) CIK: 0001719461 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55320 | Film No.: 201358148